Ceres Nanosciences, Inc.
Manassas, VA
- UEI
- GL6HXTK992Y4
- CAGE
- 6KXK0
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9460 Innovation Dr, Manassas, VA 20110, USA
- Website
- ceresnano.com
- Founded
- 2008
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $1,400,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
About the company
Ceres Nanosciences, Inc. is a for-profit corporate entity that provides nanotechnology-enabled products and services to advance diagnostics and disease monitoring. Through federal contract and grant awards, Ceres Nanosciences supports public health, medical research, and national security missions.
Ceres Nanosciences has received over $16 million in federal contracts to manufacture nanoparticle products, develop diagnostic tests, and build surveillance capabilities. As a prime contractor, Ceres received awards from the NIH and CDC to produce nanotrap particles for COVID-19 testing under the RADx program, enable next-generation sequencing for public health surveillance, and monitor antimicrobial resistance. A subcontract from Emory University supports point-of-care testing technologies.
Through federal grants, Ceres Nanosciences conducts research to improve disease detection and drug testing. Ceres received awards from the NIH and CDC as a prime grantee to develop viral enrichment capabilities for surveillance, clarify and characterize animal serum, and lower the limit of detection for fentanyl testing. Funding sources included the National Institute of General Medical Sciences, National Institute on Drug Abuse, and Centers for Disease Control and Prevention.
Quick answers
Is Ceres Nanosciences, Inc. registered in SAM.gov?
Yes. Ceres Nanosciences, Inc.'s SAM.gov registration is active through May 11, 2027.
What is Ceres Nanosciences, Inc.'s CAGE code?
Ceres Nanosciences, Inc.'s CAGE code is 6KXK0, and its Unique Entity ID (UEI) is GL6HXTK992Y4.
How much has Ceres Nanosciences, Inc. received in federal contracts?
Federal contracts obligated $1,400,000 to Ceres Nanosciences, Inc. in fiscal years 2023 through 2027.
What is Ceres Nanosciences, Inc.'s most recent federal award?
Ceres Nanosciences, Inc.'s most recent federal contract award is Target-capture technology for healthcare-related bacteria that are prone to carry antimicrobial resistant genes (75D30121P12401), from CDC Pittsburgh, on September 7, 2021.
On GovTribe
See Ceres Nanosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors